C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 471/14 (2006.01) A61K 31/437 (2006.01) C07D 471/22 (2006.01)
Patent
CA 2594674
Substituted fused [1,2]imidazo[4,5-c] ring compounds (e.g., imidazo[4,5- c]quinolines, 6,7,8,9-tetrahydroimidazo[4,5-c]quinolines, imidazo[4,5- c]naphthyridines, and 6,7,8,9-tetrahydroimidazo[4,5-c]naphthyridines) with a - CH(-R1)- group in the fused ring at the 1-position of the imidazo ring, wherein Rl includes a functional group, for example, an amide, sulfonamide, urea, carbamate, ester, ketone, ether, a thio analog of the forgoing, sulfone, oxime, or hydroxylamine, pharmaceutical compositions containing the compounds, intermediates, methods of making the compounds, and methods of use of these compounds as immunomodulators, for inducing cytokine biosynthesis in animals and in the treatment of diseases including viral and neoplastic diseases, are disclosed.
L'invention concerne des composés [1,2]imidazo[4,5-c] substitués à noyau fusionné (par exemple, des imidazo[4,5-c]quinolines, des 6,7,8,9-tétrahydroimidazo[4,5-c]quinolines, des imidazo[4,5-c]naphthyridines et des 6,7,8,9-tétrahydroimidazo[4,5-c]naphthyridines) comprenant un groupe -CH(-R1)- dans le noyau fusionné au niveau de la position 1 du noyau imidazo, dans lequel Rl comprend un groupe fonctionnel, par exemple, un amide, un sulfonamide, une urée, un carbamate, un ester, un cétone, un éther, un analogue thio des éléments susmentionnés, un sulfone, un oxime ou un hydroxylamine. L'invention concerne également des compositions pharmaceutiques contenant lesdits composés, des intermédiaires, des procédés de préparation des composés, des procédés d'utilisation comme immunomodulateurs permettant d'induire la biosynthèse de la cytokine chez les animaux et de traiter des maladies notamment des maladies virales et néoplasiques.
Danielson Michael E.
Griesgraber George W.
Kshirsagar Tushar A.
Slania Sarah J.
3m Innovative Properties Company
Robic
LandOfFree
Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1450616